AI assistant
Imunon, Inc. — Director's Dealing 2015
Feb 24, 2015
35124_dirs_2015-02-24_bfe591d6-570c-4696-8b92-66aaf9e87def.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Celsion CORP (CLSN)
CIK: 0000749647
Period of Report: 2015-02-20
Reporting Person: EGWU, Inc. fka EGEN, Inc. (10% Owner)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2015-02-20 | Common Stock | S | 199765 | $3.30 | Disposed | 2512423 | Direct |
Footnotes
F1: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 12, 2014.
F2: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $3.13 to $3.54, inclusive. The reporting person undertakes to provide to Celsion Corporation, any security holder of Celsion Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote (2) to Form 4.